Arterial Chemoembolisation With Cisplatin vs Epirubicin for Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial
Eur. J. Cancer 2021 Sep 23;157(xx)373-382, O Aramaki, T Takayama, M Moriguchi, H Sakamoto, H Yodono, N Kokudo, N Yamanaka, S Kawasaki, Y Sasaki, K Kubota, E Otsuji, S Tanaka, Y Matsuyama, M FujiiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.